Shares of Oculus Innovative Sciences Inc. (NASDAQ:OCLS) were down 4.6% during trading on Monday . The stock traded as low as $4.11 and last traded at $4.12, with a volume of 67,342 shares changing hands. The stock had previously closed at $4.32.

Several analysts have commented on OCLS shares. Maxim Group reissued a “buy” rating and set a $3.00 price target on shares of Oculus Innovative Sciences in a research report on Wednesday, April 20th. Zacks Investment Research lowered shares of Oculus Innovative Sciences from a “hold” rating to a “sell” rating in a research report on Tuesday, March 29th.

The company’s 50-day moving average is $4.57 and its 200 day moving average is $4.96. The company’s market capitalization is $18.38 million.

Oculus Innovative Sciences (NASDAQ:OCLS) last issued its quarterly earnings data on Thursday, June 16th. The company reported ($0.16) earnings per share (EPS) for the quarter. On average, equities research analysts anticipate that Oculus Innovative Sciences Inc. will post ($0.37) earnings per share for the current fiscal year.

Oculus Innovative Sciences, Inc is a specialty device and pharmaceutical company. The Company develops and markets solutions for the treatment of dermatological conditions and advanced tissue care in both humans and animals. The Company offers wound care products which are sold into the human and animal healthcare markets in the United States, Mexico and Europe.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.